14G Stock Overview Through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. More details
Rewards Risk Analysis + 2 more risks
See All Risk Checks Capture your thoughts, links and company narrative
Assure Holdings Corp. Competitors Price History & Performance
Summary of share price highs, lows and changes for Assure Holdings Historical stock prices Current Share Price US$4.00 52 Week High US$169.00 52 Week Low US$4.00 Beta 1.26 1 Month Change 0% 3 Month Change -24.81% 1 Year Change -89.58% 3 Year Change -95.09% 5 Year Change n/a Change since IPO -97.44%
Recent News & Updates Assure Holdings Corp. announced delayed 10-Q filing Nov 19
Assure Holdings Corp. Announces Chief Financial Officer Changes Oct 08 Assure Holdings Corp. has withdrawn its Follow-on Equity Offering in the amount of $23.203125 million. Sep 21
Assure Holdings Corp. announced delayed 10-Q filing Aug 16
Assure Holdings Corp.(OTCPK:IONM) dropped from S&P TMI Index Jul 26
Assure Holdings Corp.(OTCPK:IONM) dropped from NASDAQ Composite Index Jul 25 See more updates Assure Holdings Corp. announced delayed 10-Q filing Nov 19
Assure Holdings Corp. Announces Chief Financial Officer Changes Oct 08 Assure Holdings Corp. has withdrawn its Follow-on Equity Offering in the amount of $23.203125 million. Sep 21
Assure Holdings Corp. announced delayed 10-Q filing Aug 16
Assure Holdings Corp.(OTCPK:IONM) dropped from S&P TMI Index Jul 26
Assure Holdings Corp.(OTCPK:IONM) dropped from NASDAQ Composite Index Jul 25 Nasdaq Hearing Panel Determines to Delist Common Stock of Assure Holdings Jul 24
Assure Holdings Receives Non-Compliance Notice Regarding 10-Q Filing for the Period Ended March 31, 2024 May 29 Assure Holdings Corp. announced delayed 10-Q filing May 18
Nasdaq Hearings Panel Grants Assure Holdings an Extension to Regain Compliance with the Continued Listing Requirements for The Nasdaq Capital Market May 17
Assure Holdings Receives Notice from Nasdaq Due to Delinquency in the Timely Filing of the Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023 Under Nasdaq Listing Rule 5250(c)(1) Apr 25 Assure Holdings Corp. announced delayed annual 10-K filing Apr 03
Assure Holdings Corp. Announces to Appoint Suren Ajjarapu as Chairman
Assure Holdings Corp. Receives A Determination Letter from Listing Qualifications Staff of Nasdaq Jan 31
Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1) Nov 26
Assure Holdings Corp. announced delayed 10-Q filing Nov 17
Nasdaq Grants an Extension of Time to Assure Holdings to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement Nov 03
Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with $2.5 Million Stockholders’ Equity Requirement for Continued Listing on The Nasdaq Capital Market Aug 25
Assure Holdings Receives Non-Compliance Notice From Nasdaq Aug 23
Assure Holdings Corp. to Report Q2, 2023 Results on Aug 14, 2023 Aug 09
Assure Holdings Corp. (NasdaqCM:IONM) completed the acquisition of Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million. Aug 04
Assure Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement as Set Forth in Nasdaq Listing Rule 5550(a)(2) Jul 30 Assure Holdings Corp. (NasdaqCM:IONM) signed a Letter of Intent to acquire Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million. Jun 27
Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6 million. May 13
Assure Holdings Corp. Provides Revenue Guidance for the Fourth Quarter of 2022 Nov 16
Assure Holdings Corp., Annual General Meeting, Dec 28, 2022 Nov 12
Assure Holdings Corp. to Report Q3, 2022 Results on Nov 14, 2022 Nov 11
Assure Holdings Corp. Announces Executive Changes Nov 02
Assure Holdings Receives Letter from the Listing Qualifications Staff of Nasdaq Oct 17 Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6.245217 million. Aug 23
Assure Holdings Corp. to Report Q2, 2022 Results on Aug 15, 2022 Aug 10
Assure Holdings Corp. Provides Operational Guidance for the Year 2022 May 17
Assure Holdings Corp. to Report Q1, 2022 Results on May 16, 2022 May 07
Assure Holdings Corp. Appoints James Watt as National Technologist Director Apr 27
Assure Holdings Corp. Announces Management Change Apr 20
Assure Announces Voluntary Delisting from TSX Venture Exchange Jan 22
Assure Holdings Corp. announced that it has received $0.435157 million in funding Dec 01
Assure Holdings Corp. announced that it expects to receive $0.435157 million in funding Nov 27
Third quarter 2021 earnings released: EPS US$0.008 (vs US$0.14 loss in 3Q 2020) Nov 17
Second quarter 2021 earnings released: US$0.023 loss per share (vs US$0.37 loss in 2Q 2020) Aug 18
First quarter 2021 earnings released: US$0.022 loss per share (vs US$0.017 loss in 1Q 2020) May 15
Assure Holdings Corp. Raises Production Guidance for the Year 2021 May 15
Assure Holdings Corp. (TSXV:IOM) completed the acquisition of all assets of Sentry Neuromonitoring, LLC. May 04
Assure Holdings Corp. Provides Production Guidance for the Year 2021 Mar 28
Full year 2020 earnings released: US$0.41 loss per share (vs US$0.074 profit in FY 2019) Mar 27
Assure Holdings Corp. Appoints Isador Lieberman to its Medical Advisory Committee Mar 20
Founder & Director recently sold €445k worth of stock Mar 12
Assure Holdings Corp. (TSXV:IOM) signed a term sheet to acquire Sentry Neuromonitoring, LLC for $3.5 million. Feb 26
New 90-day high: €0.98 Feb 13
Assure Holdings Corp. Adds New Surgeons to its Platform in Arizona Feb 02
New 90-day high: €0.95 Jan 20
New 90-day high: €0.88 Dec 05
Assure Holdings Corp. announced that it has received $10.46893 million in funding from Manchester Management Company, LLC and other investors Dec 03
Assure Holdings Corp. announced that it expects to receive $10.28096 million in funding Dec 01
Assure Holdings Corp. to Report Q3, 2020 Results on Nov 30, 2020 Nov 17
New 90-day low: €0.55 Nov 02
Assure Holdings Corp. Promotes Craig Caviness to Vice President of Corporate Development from His Former Role as Eastern U.S. Territory Director Oct 27 Assure Holdings Corp. announced that it expects to receive $0.0405 million in funding
Assure Holdings Corp. to Report Q2, 2020 Results on Aug 28, 2020 Aug 07
New 90-day low - €0.58 Jul 28
Assure Holdings Corp. announced a financing transaction Jul 23
Assure Holdings Corp. to Report Q1, 2020 Results on Jul 14, 2020 Jul 08 Shareholder Returns 14G DE Healthcare DE Market 7D 0% 3.9% 3.0% 1Y -89.6% 31.0% 12.8%
See full shareholder returns
Return vs Market: 14G underperformed the German Market which returned 5.9% over the past year.
Price Volatility Is 14G's price volatile compared to industry and market? 14G volatility 14G Average Weekly Movement n/a Healthcare Industry Average Movement 4.8% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 14G's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 14G's volatility change over the past year.
About the Company Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.
Show more Assure Holdings Corp. Fundamentals Summary How do Assure Holdings's earnings and revenue compare to its market cap? 14G fundamental statistics Market cap €990.86k Earnings (TTM ) -€29.80m Revenue (TTM ) €9.16m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 14G income statement (TTM ) Revenue US$9.83m Cost of Revenue US$14.69m Gross Profit -US$4.86m Other Expenses US$27.11m Earnings -US$31.97m
Last Reported Earnings
Mar 31, 2023
Earnings per share (EPS) -29.02 Gross Margin -49.45% Net Profit Margin -325.30% Debt/Equity Ratio 905.6%
How did 14G perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2023/05/30 22:38 End of Day Share Price 2023/03/03 00:00 Earnings 2023/03/31 Annual Earnings 2022/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Assure Holdings Corp. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution William Sutherland Benchmark Company Scott Henry Roth Capital Partners James Sidoti Sidoti & Company, LLC
Show 0 more analysts 
